Unternehmensaktivitäten und -maßnahmen

Bayer

Mitglied des UN Global Compact

Hauptsitz in Deutschland

Bayer website

🔎 Run a search for “Bayer”

Get RSS feed of these results

Alle Stories

Artikel
1 June 2002
+ English - Verbergen

Autor/in: Friends of the Earth

Friends of the Earth today publishes details of "Ten Planet Trashers", companies whose behaviour since Rio shows the need for binding rules on corporate behaviour. [the 10 companies: Exxon Mobil (Esso), AMEC, Premier Oil, ICI, Scotts, Barclays,...

Mehr

Artikel
8 May 2002
+ English - Verbergen

Autor/in: UN Wire

German drug maker Bayer yesterday said it has signed an agreement with the World Health Organization to develop an affordable malaria vaccine for use in developing countries.

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
1 April 2002
+ English - Verbergen

Autor/in: Oxford Analytica, prepared for International Business Leaders Forum and TimeFORTUNE

[refers to H.C. Stark of Germany (a subsidiary of Bayer AG), Ulba of Kazakhstan, and Cabot Corporation of the United States; French companies Safmarine, SDV-Transintra, Martinair; OSLEG, a company owned by Zimbabwe's army; Zimbabwean investor John...

Mehr

Story
4 January 2002
+ English - Verbergen
Artikel
5 November 2001
+ English - Verbergen

Autor/in: Kavaljit Singh, Asia-Europe Dialogue Project, on CorpWatch website

This article, which lays out the issues surrounding drug patents, WTO rules and public health, was written before the recent WTO meeting in Doha, Qatar...We believe this piece is still timely because it gives context to the fierce fight over drug...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
31 October 2001
+ English - Verbergen

Autor/in: Patti Waldmeir, Financial Times

...Bayer, the Cipro patent-holder, was condemned for using its patent to keep generic anti-anthrax drugs out of the hands of soon-to-be-sick Americans. The US secretary of health hinted he might abrogate the company's patent rights - and then used that...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
25 October 2001
+ English - Verbergen

Autor/in: Ed Silverman, Star-Ledger [New Jersey]

Rather than suffer a bruising battle for its Cipro patent and risk more damage to its image, the German drug giant will sell the anthrax-fighting antibiotic to the [U.S.] federal government at a drastically reduced price -- 95 cents a tablet, about...

Mehr

Artikel
25 October 2001
+ English - Verbergen

Autor/in: Geoff Dyer and Bettina Wassener, Financial Times

The US government was expected to announce yesterday it had reached a deal with Bayer over the supply of Cipro, which would involve the German group reducing the price of its anthrax treatment. The agreement could help defuse the controversy over the...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
25 October 2001
+ English - Verbergen

Autor/in: Stop Patient Abuse Now [SPAN]

The German-based Bayer corporation has prevailed upon the Department of Health and Human Services to put its interests before the safety of U.S. citizens in the Cipro deal struck this week by Secretary Tommy Thompson, according to the SPAN Coalition.

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
24 October 2001
+ English - Verbergen

Autor/in: Laura Meckler, Associated Press

Federal officials and Bayer Corp. agreed Wednesday on a lower price for the government to stockpile the antibiotic Cipro, the most popular anti-anthrax drug. The pharmaceutical company will sell the government 100 million pills at 95 cents each, a cost...

Mehr

  • Betreffende Unternehmen: Bayer